Oncolytics Biotech ONCY
NASDAQ ONCY
$0.84 +0.04 (+5.16%)
At close: Aug 21, 2026 · 4:00 PM EDT

Oncolytics Biotech (ONCY) Amortizatization of Intangibles (2009 - 2010)

Oncolytics Biotech (ONCY) posted quarterly Amortizatization of Intangibles of -$3.6 million for Q3 2010, down 200.0% year-over-year from $3.6 million in Q3 2009, and down 200.0% quarter-over-quarter from $3.6 million in Q2 2010.

Oncolytics Biotech (ONCY) Amortizatization of Intangibles (2009 - 2010) Analysis & Trends

Oncolytics Biotech (ONCY) has reported Amortizatization of Intangibles for 2 consecutive years, with -$3.6 million the latest figure, recorded in Q3 2010.

  • In Q3 2010, Amortizatization of Intangibles fell 200.0% year-over-year to -$3.6 million; the TTM figure through Dec 2010 stood at -$3.6 million (down 211.11% YoY), while the FY2010 annual figure was -$3.6 million, down 1900.0% from the prior year.
  • Amortizatization of Intangibles declined to -$3.6 million in Q3 2010 per ONCY's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.6 million in Q3 2009 and bottomed at -$3.6 million in Q1 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Oncolytics Biotech 101.16 Mn 101.16 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2010 -3.62 Mn
Sep 30, 2010 -3.62 Mn
Jun 30, 2010 3.62 Mn
Jun 30, 2010 3.62 Mn
Mar 31, 2010 -3.62 Mn
Mar 31, 2010 -3.62 Mn
Dec 31, 2009 -361,500.00
Dec 31, 2009 -361,500.00
Sep 30, 2009 3.62 Mn
Sep 30, 2009 3.62 Mn
Jun 30, 2009 90,375.00
Jun 30, 2009 90,375.00
Mar 31, 2009 -90,375.00
Mar 31, 2009 -90,375.00